통증 관리 의약품 시장 보고서 : 약물 종류별, 적응증별, 유통 채널별, 지역별(2025-2033년)

The global pain management drugs market size reached USD 71.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 88.7 Billion by 2033, exhibiting a growth rate (CAGR) of 2.32% during 2025-2033. The market is experiencing robust growth driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, heightened awareness and education about pain management, the implementation of supportive government and regulatory frameworks, and the rising demand for effective post-operative pain management.

Pain Management Drugs Market Analysis:

Market Growth and Size: The market is witnessing stable growth, driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, and the growing demand for effective and safer pain relief options.

Major Market Drivers: Key drivers influencing the market growth include the rising incidence of arthritis and cancer, rapid technological advancements in drug development, increasing awareness and education about pain management, and the implementation of supportive government policies.

Key Market Trends: The key market trends involve the ongoing shift towards the development of non-opioid medications, driven by the global opioid crisis and the need for safer pain management options. Additionally, the increasing focus on personalized medicine and pharmacogenomics that offer more targeted and effective pain management strategies, is bolstering the market growth.

Geographical Trends: North America leads the market due to advanced healthcare systems, high prevalence of chronic pain, and ongoing efforts to develop alternative pain management therapies. Other regions are also showing significant growth, fueled by increasing healthcare infrastructure, rising chronic disease prevalence, and expanding pharmaceutical sectors.

Competitive Landscape: The market is characterized by the active involvement of key players who are engaged in strategic initiatives such as research and development (R&D), collaborations, and mergers and acquisitions to enhance their market position. Furthermore, companies are focusing on innovation and expanding their product portfolios to include novel and effective pain management solutions.

Challenges and Opportunities: The market faces various challenges, such as the need for balancing efficacy with safety in opioid use and navigating complex regulatory environments. However, the development of new therapeutic areas, and growing focus on personalized pain management approaches, are creating new opportunities for the market growth.

Pain Management Drugs Market Trends:

Increasing prevalence of chronic diseases

The rising incidence of chronic diseases, such as arthritis, cancer, diabetes, and heart disease, necessitating the use of pain management drugs, is one of the major factors boosting the market growth. Moreover, the increasing utilization of pain management drugs to improve the quality of life of patients, is acting as a growth-inducing factor. Additionally, the growing geriatric population across the globe who are susceptible to chronic conditions, such as osteoarthritis and neuropathic pain, is amplifying the market growth. In addition to this, the rising lifestyle changes, leading to an increase in risk factors, like obesity and physical inactivity, is driving the market growth. Furthermore, the increasing complexity of pain in chronic diseases requiring a multimodal approach to pain management is expanding the market growth.

Rapid advancements in pain management therapies

The rapid technological advancements in pain management, leading to the development of new and more effective drugs, including biologics and targeted therapies, is creating a positive outlook for the market growth. In line with this, the rising improvements in the efficacy of treatments to reduce side effects associated with traditional pain management drugs, is favoring the market growth. Additionally, the increasing focus by the pharmaceutical industry on research and development (R&D), leading to the introduction of drugs with better pain management profiles, is creating a positive outlook for the market growth. Additionally, the rising popularity of personalized medicine and pharmacogenomics that enable more targeted and effective pain management strategies, is anticipated to drive the market growth.

Growing awareness about pain management

The increasing awareness and education about pain management among healthcare professionals and patients is a major factor propelling the market growth. Moreover, the rising understanding and training among healthcare providers who are equipped to prescribe appropriate pain management drugs, is contributing to the market growth. Along with this, the growing education among patients about the benefits and implications of drugs, prompting them to seek treatment for their pain, is boosting the market growth. Besides this, the implementation of various awareness campaigns and educational programs by governments and healthcare organizations is acting as a growth-inducing factor. In line with this, the introduction of several initiatives focusing on the management of chronic pain conditions, like fibromyalgia and neuropathic pain to increase awareness about the conditions and the available treatment options, is positively influencing the market growth.

Rising government and regulatory support

The imposition of various government initiatives and policies that support the development and approval of new drugs is creating a positive outlook for the market growth. In line with this, the introduction of fast-track approvals and incentives for orphan drug development that encourage pharmaceutical companies to invest in new pain management therapies, is anticipated to drive the market growth. Furthermore, the implementation of government-funded healthcare programs and reimbursement policies that directly influence the accessibility and affordability of pain management drugs, is providing a considerable boost to the market growth. Additionally, the growing establishment of programs to increase access to pain management drugs in underserved areas, recognizing pain management as a key component of public health, is fostering the market growth. Along with this, the rising initiatives in funding and grants for research in novel pain management therapies, encouraging innovation and development is providing an impetus to the market growth.

Increasing surgical procedures and post-operative pain management

The rising surgical procedures across the globe, driving the demand for pain management drugs is fueling the market growth. Moreover, the widespread utilization of post-operative pain management for patient recovery is boosting the market growth. Besides this, the increasing prevalence of elective and minimally invasive (MI) surgical procedures, leading to a corresponding rise in the demand for effective pain management drugs is anticipated to drive the market growth. Surgical procedures result in acute pain that requires management to facilitate patient recovery and prevent complications. In addition to this, effective post-operative pain management improves patient comfort and reduces the risk of post-surgical complications such as thrombosis, pulmonary issues, and chronic pain syndromes. Apart from this, the growing emphasis on enhanced recovery after surgery (ERAS) protocols in hospitals, highlighting the importance of effective pain management strategies, is creating a positive outlook for the market.

Pain Management Drugs Industry Segmentation:

Breakup by Drug Class:

• NSAIDs
• Anesthetics
• Anticonvulsants
• Antimigraine Agents
• Antidepressants
• Opioids
• Others

Opioids accounts for the majority of the market share

Breakup by Indication:

• Musculoskeletal Pain
• Surgical and Trauma Pain
• Cancer Pain
• Neuropathic Pain
• Migraine Pain
• Obstetrical Pain
• Fibromyalgia Pain
• Burn Pain
• Dental/Facial Pain
• Pediatric Pain
• Others

Musculoskeletal pain holds the largest share in the industry

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Hospital pharmacies represents the leading market segment

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

North America leads the market, accounting for the largest pain management drugs market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Abbott Laboratories, Inc.
• Pfizer, Inc.
• Eli Lilly & Company
• Endo International plc
• F. Hoffmann-La Roche AG
• Bausch Health Companies, Inc.
• Merck & Co. Inc.
• Allergen Inc.
• Novartis International AG
• Johnson & Johnson Private Limited
• GlaxoSmithKline Plc
• Purdue Pharma L.P.

Key Questions Answered in This Report

• 1.What was the global pain management drugs market size in 2024?
• 2.How will the global pain management drugs market perform over the next five years 2025-2033?
• 3.What is the impact of COVID-19 on the global pain management drugs market?
• 4.What are the key global pain management drugs market drivers?
• 5.What are the major trends in the global pain management drugs market?
• 6.What is the leading drug class in the global pain management drugs market?
• 7.What is the major indication in the global pain management drugs market?
• 8.What is the global pain management drugs market breakup by distribution channel?
• 9.What are the major regions in the global pain management drugs market?
• 10.Who are the leading pain management drug manufacturers?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Pain Management Drugs Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Drug Class
• 5.5 Market Breakup by Indication
• 5.6 Market Breakup by Distribution Channel
• 5.7 Market Breakup by Region
• 5.8 Market Forecast

6 Market Breakup by Drug Class

• 6.1 NSAIDs
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Anesthetics
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Anticonvulsants
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Antimigraine Agents
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Antidepressants
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Opioids
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Others
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Indication

• 7.1 Musculoskeletal Pain
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Surgical and Trauma Pain
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Cancer Pain
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Neuropathic Pain
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Migraine Pain
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Obstetrical Pain
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Fibromyalgia Pain
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast
• 7.8 Burn Pain
  • 7.8.1 Market Trends
  • 7.8.2 Market Forecast
• 7.9 Dental/Facial Pain
  • 7.9.1 Market Trends
  • 7.9.2 Market Forecast
• 7.10 Pediatric Pain
  • 7.10.1 Market Trends
  • 7.10.2 Market Forecast
• 7.11 Others
  • 7.11.1 Market Trends
  • 7.11.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Hospital Pharmacies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Retail Pharmacies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Pharmacies
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Europe
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Asia Pacific
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Middle East and Africa
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Latin America
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

• 13.1 Price Indicators
• 13.2 Price Structure
• 13.3 Margin Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories, Inc.
  • 14.3.2 Pfizer, Inc.
  • 14.3.3 Eli Lilly & Company
  • 14.3.4 Endo International plc
  • 14.3.5 F. Hoffmann-La Roche AG
  • 14.3.6 Bausch Health Companies, Inc.
  • 14.3.7 Merck & Co. Inc.
  • 14.3.8 Allergen Inc.
  • 14.3.9 Novartis International AG
  • 14.3.10 Johnson & Johnson Private Limited
  • 14.3.11 GlaxoSmithKline Plc
  • 14.3.12 Purdue Pharma L.P